The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2020 | The tumor microenvironment: lung cancer
Kenneth O’Byrne, MD, MB, BCh, BAO, Princess Alexandra Hospital & Queensland University of Technology, Woolloongabba, Australia, talks on the role of the tumor microenvironment in lung cancer and touches on nanostring technology that allows for the in-depth investigation of this important aspect of cancer disease biology. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.
